4
Changes in Ownership
Nautilus Biotechnology, Inc. Filed Acc 0001062993-22-015186
Options or other derivatives
- Director acquired 86,467 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC Director | 2022-06-15 | Grant or award · Stock Option (Right to Buy) | +86,467 | 86,467 | I: show line 1 in the form |
Loading xslF345X03/form4.xml…